Collegium Pharmaceutical Inc (COLL)
34.25
+0.43
(+1.27%)
USD |
NASDAQ |
May 24, 16:00
34.98
+0.73
(+2.13%)
Pre-Market: 20:00
Collegium Pharmaceutical Net Income (Quarterly): 27.71M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 27.71M |
| December 31, 2023 | 31.94M |
| September 30, 2023 | 20.63M |
| June 30, 2023 | 13.01M |
| March 31, 2023 | -17.43M |
| December 31, 2022 | -7.199M |
| September 30, 2022 | 0.457M |
| June 30, 2022 | -5.191M |
| March 31, 2022 | -13.07M |
| December 31, 2021 | -25.03M |
| September 30, 2021 | 8.046M |
| June 30, 2021 | 72.84M |
| March 31, 2021 | 15.66M |
| December 31, 2020 | 6.958M |
| September 30, 2020 | 11.29M |
| June 30, 2020 | 8.058M |
| March 31, 2020 | 0.45M |
| December 31, 2019 | -2.201M |
| September 30, 2019 | -6.109M |
| June 30, 2019 | -4.712M |
| March 31, 2019 | -9.70M |
| Date | Value |
|---|---|
| December 31, 2018 | 9.086M |
| September 30, 2018 | -16.50M |
| June 30, 2018 | -13.06M |
| March 31, 2018 | -18.65M |
| December 31, 2017 | -17.40M |
| September 30, 2017 | -13.26M |
| June 30, 2017 | -21.12M |
| March 31, 2017 | -23.08M |
| December 31, 2016 | -27.56M |
| September 30, 2016 | -26.44M |
| June 30, 2016 | -24.52M |
| March 31, 2016 | -15.65M |
| December 31, 2015 | -9.525M |
| September 30, 2015 | -9.362M |
| June 30, 2015 | -4.674M |
| March 31, 2015 | -3.694M |
| December 31, 2014 | -3.469M |
| September 30, 2014 | -6.556M |
| June 30, 2014 | -4.117M |
| March 31, 2014 | -3.773M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-25.03M
Minimum
Dec 2021
72.84M
Maximum
Jun 2021
6.806M
Average
3.708M
Median
Net Income (Quarterly) Benchmarks
| Inotiv Inc | -48.08M |
| Catalyst Pharmaceuticals Inc | 23.28M |
| Supernus Pharmaceuticals Inc | 0.124M |
| Aquestive Therapeutics Inc | -12.83M |
| NovaBay Pharmaceuticals Inc | -3.214M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 144.92M |
| Total Expenses (Quarterly) | 95.45M |
| EPS Diluted (Quarterly) | 0.71 |
| Enterprise Value | 1.426B |
| Gross Profit Margin (Quarterly) | 63.11% |
| Profit Margin (Quarterly) | 19.12% |
| Earnings Yield | 7.04% |
| Operating Earnings Yield | 11.91% |
| Normalized Earnings Yield | 7.036 |